Canton Strategic (CNTN) vs Oramed Pharmaceuticals (ORMP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Oramed Pharmaceuticals (ORMP) has outperformed Canton Strategic (CNTN) over the past year, gaining 76.2% versus a loss of 25.2%. Oramed Pharmaceuticals is the larger company by market cap ($181.8 million vs $180.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNTN | ORMP |
|---|---|---|
| Share price | $2.26 | $4.37 |
| Market cap | $180.08M | $181.78M |
| 1-day change | -3.42% | -0.23% |
| YTD return | -25.41% | +53.33% |
| 1-year return | -25.17% | +76.21% |
| 5-year return | — | -80.19% |
| P/E ratio (TTM) | — | 1.06 |
| EPS (TTM) | $-0.10 | $4.13 |
| Dividend yield | 0.00% | 5.71% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.89 | $5.47 |
| 52-week low | $1.75 | $2.09 |
| Distance from 52-week high | -67.20% | -20.11% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +60.18% |
| Average volume | 752.44K | 194.48K |
| Shares outstanding | 79.68M | 41.60M |
| Employees | 12 | — |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ORMP has outperformed CNTN by 101.4 percentage points over the past year.
- Oramed Pharmaceuticals offers a meaningfully higher dividend yield (5.71% vs 0.00%).
About Canton Strategic
CNTN stock →Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States.
Healthcare · Biotechnology · 12 employees
About Oramed Pharmaceuticals
ORMP stock →Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.
Healthcare · Biotechnology
CNTN vs ORMP FAQ
Which is bigger, Canton Strategic or Oramed Pharmaceuticals?
Oramed Pharmaceuticals (ORMP) is larger, with a market capitalization of $181.78M compared with $180.08M for Canton Strategic (CNTN).
Which stock has performed better over the past year, CNTN or ORMP?
ORMP returned +76.21% over the past 12 months, compared with -25.17% for CNTN (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Canton Strategic or Oramed Pharmaceuticals?
Oramed Pharmaceuticals pays a dividend yielding 5.71%, while Canton Strategic does not currently pay a regular dividend.
Are Canton Strategic and Oramed Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.